CoChat
Sign Up
Cited by 3Multiple Myeloma Research and TreatmentsBone health and treatmentsProstate Cancer Diagnosis and Treatment

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

NCCN guidelines focus on treatment options for patients with multiple myeloma: Recommendations highlight important updates specific to systemic therapy options for those with newly diagnosed or previously treated multiple myeloma

Open access
Nierengarten, Mary Beth·2025·Cancer
DOI 10.1002/cncr.70014
Open this paper in CoChat — free accountOpen PDF

Abstract

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, recommendations highlight important updates specific to systemic therapy options for those with newly diagnosed or previously treated multiple myeloma. In addition, a persistent PSA level following radical prostatectomy for prostate cancer is associated with a worse prognosis, and outcomes show a reduction in treatment failure associated with dose‐escalated, hypofractionated radiation therapy for localized prostate cancer.

Overview

Integrity signals

Registry

Crossref · 10.1002/cncr.70014

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 1

  1. 10.1056/NEJMoa240902 · DOI

Cited by

Related

See all

Metadata

Authors
Nierengarten, M. B.
Corresponding author
Nierengarten, Mary Beth
Venue
Cancer
Publisher
Wiley
Published
2025-08-31
Volume
131
Issue
17
Pages
e70014-e70014
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
DOI
10.1002/cncr.70014
OpenAlex
W4413867774
Cited by
3
References
2
Citations by year
2026: 2 · 2025: 1
FWCI
2.22
Type
journal article
Language
en
Open access
Licence
Locations
  • Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Keywords
multiple myeloma, NCCN guidelines, systemic therapy, treatment options, newly diagnosed multiple myeloma, prostate cancer, prognosis, hypofractionated radiotherapy, dose escalation, localized prostate cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review